Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features

Barbara J. McClure; Manika Pal; Susan L. Heatley; Jacqueline Rehn; Caitlin Schutz; James Breen; Nicola C. Venn; Rosemary Sutton; Seong Lin Khaw; David Yeung; Deborah White

doi:10.1111/bjh.17995

Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features

Barbara J. McClure, Manika Pal, Susan L. Heatley, Jacqueline Rehn, Caitlin Schutz, James Breen, Nicola C. Venn, Rosemary Sutton, Seong Lin Khaw, David Yeung, Deborah White

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1407-1411
Number of pages	5
Journal	British Journal of Haematology
Volume	196
Issue number	6
DOIs	https://doi.org/10.1111/bjh.17995
Publication status	Published or Issued - Mar 2022

Keywords

B-cell acute lymphoblastic leukaemia (B-ALL)
CRLF2-rearranged
NUTM1-rearranged
adult B-ALL
congenital B-ALL

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.17995

Cite this

@article{ae2b64ab8f264bad9bd9dd4ea2db5afa,

title = "Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features",

keywords = "B-cell acute lymphoblastic leukaemia (B-ALL), CRLF2-rearranged, NUTM1-rearranged, adult B-ALL, congenital B-ALL",

author = "McClure, {Barbara J.} and Manika Pal and Heatley, {Susan L.} and Jacqueline Rehn and Caitlin Schutz and James Breen and Venn, {Nicola C.} and Rosemary Sutton and Khaw, {Seong Lin} and David Yeung and Deborah White",

note = "Funding Information: DLW receives research support from BMS, and honoraria from BMS and AMGEN. DTY receives research support from BMS and Novartis, and honoraria from BMS, Novartis, Pfizer and AMGEN. SLK has received institutional research funding from AbbVie, Novartis, Jazz Pharmaceuticals, and Bristol‐Myers Squibb, and honoraria from Novartis, Jazz and Amgen. None of these agencies have had a role in the preparation of this manuscript. All other authors declare no conflicts of interest. Funding Information: The authors would like to acknowledge the contribution of the South Australian Genomics Centre (SAGC, SA, AUS) in the generation of data used in this publication. THE SAGC is supported by its founding partner institutes and by BioPlatforms Australia as part of the Australian Government{\textquoteright}s National Collaborative Research Infrastructure Strategy (NCRIS). The authors would also like to acknowledge the ACRF Cellular Imaging and Cytometry Core Facility (SAHMRI, Adelaide, SA, AUS) and the Genetics and Molecular Pathology at SA Pathology, Adelaide, SA, Australia. DLW is an NHMRC R.D. Wright II Fellow and a Beat Cancer Principal Research Fellow. DTY is an NHMRC Early Career Fellow. SLH is The Kids{\textquoteright} Cancer Project Fellow. SLK is supported by the Children{\textquoteright}s Cancer Foundation and the Department of Health and Human Services through the Victorian Cancer Agency (Project 134), Specialised Center of Research (SCOR) grant 7015‐18 from the Lymphoma and Leukemia Society and Vohra Family Foundation. This work was supported by funding from the National Health and Medical Research Council, Australia (NHRMC) (APP1057746); Cancer Australia PdCCR APP1128727; the Australian Genomics Health Alliance (AGHA); Beat Cancer; the Leukaemia Foundation and Bristol‐Meyers Squibb Company to DLW; Contributing Haematologist Committee (CHC) to DTY; and Australian Research Training Program (RTP) to JR. ",

year = "2022",

month = mar,

doi = "10.1111/bjh.17995",

language = "English",

volume = "196",

pages = "1407--1411",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features

AU - McClure, Barbara J.

AU - Pal, Manika

AU - Heatley, Susan L.

AU - Rehn, Jacqueline

AU - Schutz, Caitlin

AU - Breen, James

AU - Venn, Nicola C.

AU - Sutton, Rosemary

AU - Khaw, Seong Lin

AU - Yeung, David

AU - White, Deborah

N1 - Funding Information: DLW receives research support from BMS, and honoraria from BMS and AMGEN. DTY receives research support from BMS and Novartis, and honoraria from BMS, Novartis, Pfizer and AMGEN. SLK has received institutional research funding from AbbVie, Novartis, Jazz Pharmaceuticals, and Bristol‐Myers Squibb, and honoraria from Novartis, Jazz and Amgen. None of these agencies have had a role in the preparation of this manuscript. All other authors declare no conflicts of interest. Funding Information: The authors would like to acknowledge the contribution of the South Australian Genomics Centre (SAGC, SA, AUS) in the generation of data used in this publication. THE SAGC is supported by its founding partner institutes and by BioPlatforms Australia as part of the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS). The authors would also like to acknowledge the ACRF Cellular Imaging and Cytometry Core Facility (SAHMRI, Adelaide, SA, AUS) and the Genetics and Molecular Pathology at SA Pathology, Adelaide, SA, Australia. DLW is an NHMRC R.D. Wright II Fellow and a Beat Cancer Principal Research Fellow. DTY is an NHMRC Early Career Fellow. SLH is The Kids’ Cancer Project Fellow. SLK is supported by the Children’s Cancer Foundation and the Department of Health and Human Services through the Victorian Cancer Agency (Project 134), Specialised Center of Research (SCOR) grant 7015‐18 from the Lymphoma and Leukemia Society and Vohra Family Foundation. This work was supported by funding from the National Health and Medical Research Council, Australia (NHRMC) (APP1057746); Cancer Australia PdCCR APP1128727; the Australian Genomics Health Alliance (AGHA); Beat Cancer; the Leukaemia Foundation and Bristol‐Meyers Squibb Company to DLW; Contributing Haematologist Committee (CHC) to DTY; and Australian Research Training Program (RTP) to JR.

PY - 2022/3

Y1 - 2022/3

KW - B-cell acute lymphoblastic leukaemia (B-ALL)

KW - CRLF2-rearranged

KW - NUTM1-rearranged

KW - adult B-ALL

KW - congenital B-ALL

UR - http://www.scopus.com/inward/record.url?scp=85120995484&partnerID=8YFLogxK

U2 - 10.1111/bjh.17995

DO - 10.1111/bjh.17995

M3 - Letter

C2 - 34897646

AN - SCOPUS:85120995484

VL - 196

SP - 1407

EP - 1411

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -

Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this